Akkaramongkolporn P, Ngawhirunpat T (2003). Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration. Die Pharmazie-An Int J Pharm Sci 58(3):195-199.
Akkaramongkolporn P, Terada K, Yonemochi E (2001). Molecular properties of propranolol hydrochloride prepared as drug-resin complexes. Drug Dev Ind Pharm 27(4):359-364.
Alchin D (1998). Ion exchange resin. Chemical process in New Zealand, New Zealand Institute of Chemistry Education, PP XIII-D-1-XIII-D-7.
Alyüz B, Veli S (2009). Kinetics and equilibrium studies for the removal of nickel and zinc from aqueous solutions by ion exchange resin. J Hazard Mater 167(1-3):482-488.
Anand V, Kandarapu R, Garg S (2001). Ion-exchange resins: carrying drug delivery forward. Drug Discov Today 6(17):905-914.
Arnold JD (1986). Belleview Pharmaceutical Inc, Dihydrocodeine/ibuprofen pharmaceutical compositions and method. U.S. Patent 4, 571, 400, 1986.
Agueniou, F., Chebli, D., Reffas, A., Bouguettoucha, A., Benguerba, Y., Favier, L., & Amrane, A. (2018). Impact of TiO2-Cation Exchange Resin Composite on the Removal of Ethyl Violet. Arabian Journal for Science & Engineering (Springer Science & Business Media BV), 43(5).
Baraka A, Hall PJ, Heslop MJ (2007). Melamine–formaldehyde–NTA chelating gel resin: Synthesis, characterization and application for copper (II) ion removal from synthetic wastewater. J Hazard Mater 140(1-2):86-94.
Bellamy SA, Hughes L (2003). Rohm and Haas Company, Method for the anhydrous loading of nicotine onto ion exchange resins. U.S. Patent, 6, 607,752, 2003.
Bennett A (2007). High purity water: Advances in ion exchange technology. Filtr Separat 44(6):20-23.
Berge MS, Swarbrick J, Boylan CJ (1996). In Encyclopaedia of Pharamaceutical Technology, Vol 13.
Bhaskar R, Murthy RSR, Miglani BD, Viswanathan K (1986). Novel methods to evaluate diffusion controlled release of drug from resinate. Int J Pharm 28(1):59-66.
Brittain HG, Grant DJ (1999). Effects of polymorphism and solid-state solvation on solubility and dissolution rate. Polymorphism in pharmaceutical solids 95:279-330.
Burke GM, Mendes RW, Jambhekar SS (1986). Investigation of the applicability of ion exchange resins as a sustained release drug delivery system forpropranolol hydrochloride. Drug Dev Ind Pharm 12(5):713-732.
Calmon C (2018). Ion Exchange Pollution Control: Volume II. CRC Press.
Chaubal M.V (2003). Synthetic polymer-based ion exchange resins: excipients & actives. Drug Deliv Technol 3(5).
Chaudhry NC, Saunders L (1956). Sustained release of drugs from ion exchange resins. J Pharm Pharmacol 8(1):975-986.
Cheng YH, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L (2002). Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Control Release 79(1-3):243-254.
Cuna M, Jato JV, Torres D (2000). Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules. Int J Pharm 199(2):151-158.
Chen, X., Sun, S., Wang, X., Wen, J., Wang, Y., Cao, X., ... & Sun, R. (2020). One-pot preparation and characterization of lignin-based cation exchange resin and its utilization in Pb (II) removal. Bioresource Technology, 295, 122297.
Dambies L (2005) Existing and prospective sorption technologies for the removal of arsenic in water. Sep Sci Technol 39(3):603-627.
Dong K, Zeng A, Wang M, Dong Y, Wang K, Guo C, Yan Y, Zhang L, Shi X, Xing J (2016). In vitro and in vivo study of a colon-targeting resin microcapsule loading a novel prodrug, 3, 4, 5-tributyryl shikimic acid. RSC Adv 6(20):16882-16890.
Dyer A, Williams PA (1999). Advances in ion exchange for industry and research. In International Conference on Ion Exchange Processes 1998: North East Wales Institute. RSC.
Das, D., Das, A., & Sinha, C. (1999). A new resin containing benzimidazolylazo group and its use in the separation of heavy metals. Talanta, 48(5), 1013-1022.
Elder DP (2005). Pharmaceutical applications of ion exchange resin. J Chem Educ 82(4):575-585.
Feng Y, He B, Cao Y, Li J, Liu M, Yan F, Liang X (2010). Biodiesel production using cation-exchange resin as heterogeneous catalyst. Bioresour Technol 101(5):1518-1521.
Fisher S, Kunin R (1955). Routine exchange capacity determinations of ion exchange resins. Anal chem 27(7):1191-1194.
Fu F, Wang Q (2011). Removal of heavy metal ions from wastewaters: a review. J Environ Manage 92(3):407-418.
Gill RJ, Duncan GG, Hunscher MA (1952). Arterial Hypertension—The Therapeutic Effect of Cation-Exchange Resins. N Engl J Med247(8):271-276.
Greenleaf JE, Lin JC, Sengupta AK (2006). Two novel applications of ion exchange fibers: Arsenic removal and chemical‐free softening of hard water. Environ Prog Sustain Energy 25(4):300-311.
Greenman L, Shaler JB, Danowski TS (1953). Biochemical disturbances and clinical symptoms during prolonged exchange resin therapy in congestive heart failure. Am J Med 14(4):391-403.
Hänninen K, Kaukonen AM, Kankkunen T, Hirvonen J (2003). Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions. J Control Release 91(3):449-463.
Higaki M, Takase T, Igarashi R, Suzuki Y, Aizawa C, Mizushima Y (1998). Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin. Vaccine 16(7):741-745.
Hughes L (2005). Ion Exchange Resinates. Pharmaceutical Technology Europe 17(4):38-42.
Hughes L, Gehris A (2003). A new method of characterizing the buccal dissolution of drugs. Spring House: Rohm and Haas Research Laboratories.
Haddad, M., Oie, C., Duy, S. V., Sauvé, S., & Barbeau, B. (2019). Adsorption of micropollutants present in surface waters onto polymeric resins: Impact of resin type and water matrix on performance. Science of The Total Environment, 660, 1449-1458.
Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y (2001). Use of ion-exchange resins to prepare 100 μm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm 216(1-2):67-76.
Illum L (1999). Danbiosyst UK Ltd, Nasal drug delivery composition containing nicotine. U.S. Patent 5,935,604, 1999.
Irwin WJ, Belaid KA (1987). Drug-delivery by ion-exchange. Part I: ester pro-drugs of propranolol. Drug Dev Ind Pharm 13(9-11):2017-2031.
Irwin WJ, MacHale R, Watts PJ (1990). Drug-delivery by ion-exchnage. Part VII: Release of acidic drugs from anionic exchange resinate complexes. Drug Dev Ind Pharm 16(6):883-898.
Irwin WJ (1974). Vitro binding of drugs to Colestipol hydrochloride, J. Pharm. Sci., 63:1914-1920.
Jana S, Ghosh SK, Nath S, Pande S, Praharaj S, Panigrahi S, Basu S, Endo T, Pal T (2006). Synthesis of silver nanoshell-coated cationic polystyrene beads: A solid phase catalyst for the reduction of 4-nitrophenol. Appl Catal A Gen 313(1):41-48.
Jani R, Gan O, Ali Y, Rodstrom R, Hancock S (1994) Ion exchange resins for ophthalmic delivery. J Ocul Pharmacol Ther 10(1):57-67.
Jeong SH, Park K (2008). Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 353(1-2):195-204.
Junyaprasert VB, Manwiwattanakul G (2008). Release profile comparison and stability of diltiazem–resin microcapsules in sustained release suspensions. Int J Pharm 352(1-2):81-91.
Jia, Y., Ding, L., Ren, P., Zhong, M., Ma, J., & Fan, X. (2020). Performances and Mechanism of Methyl Orange and Congo Red Adsorbed on the Magnetic Ion-Exchange Resin. Journal of Chemical & Engineering Data, 65(2), 725-736.
Kang SY, Lee JU, Moon SH, Kim KW (2004). Competitive adsorption characteristics of Co2+, Ni2+, and Cr3+ by IRN-77 cation exchange resin in synthesized wastewater. Chemosphere 56(2):141-147.
Kanios D (2002). Compositions and methods to affect the release profile in the transdermal administration of active agents. U.S. Patent Application 09/765,932, 2002.
Kankkunen T, Huupponen I, Lahtinen K, Sundell M, Ekman K, Kontturi K, Hirvonen J (2002). Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis. Eur J Pharm Sci 16(4-5):273-280.
Kasture AV, Mahadik KR, Wadodkar SG, More HN (2002). Pharmaceutical analysis, Volume-II, Nirali prakashan. 8th edition, 43.
Kichener JA (1957). Ion Exchange Resins, New York: John Wiley & Sons.
Klasovsky F, Hohmeyer J, Bruckner A, Bonifer M, Arras J, Steffan M, Lucas M, Radnik J, Roth C, Claus P (2008). Catalytic and Mechanistic Investigation of Polyaniline Supported PtO2 Nanoparticles: A Combined in situ/operando EPR, DRIFTS, and EXAFS Study. J Phys Chem C 112(49):19555-19559.
Kouchak M, Ramezani Z, Bagheri F (2018). Preparation and evaluation of taste masking iron suspension: taking advantage of weak cationic exchange resin. AAPS Pharm Sci Tech 19(2):719-729.
Kunin R (1958). Ion Exchange Resins, New York: John Wiley & Sons.
Lu MYF, Borodkin S, Woodward L, Li P, Diesner C, Hernandez L, Vadnere M (1991). A polymer carrier system for taste masking of macrolide antibiotics. Pharm Res 8(6):706-712.
Mahore JG, Wadher KJ, Umekar MJ, Bhoyar PK (2010). Ion exchange resins: pharmaceutical applications and recent advancement. Int J Pharm Sci Rev Res 1(2):8-13.
Malik MA, Ali SW, Ahmed I (2010). Sulfonated Styrene− Divinybenzene Resins: Optimizing Synthesis and Estimating Characteristics of the Base Copolymers and the Resins. Ind Eng Chem Res 49(6):2608-2612.
Manek SP, Kamat VS (1981). Evaluation of Indion CRP-244 and CRP-254 as sustained release and taste masking agents. Indian J Pharm Sci43(11-12):209-212.
Mehndal SN, Malshe VC (1991). Eastern Pharmacist 3.
Meidar D (1978). Heterogenous Catalysis by Solid Superacids; 101. Mercury Impregnated Nafion-H Perfluorinated Resinsulfonic Acid Catalyzed Hydration of Alkynes. Synthesis 1978(09):671-672.
Mizushima Y, Kosaka Y, Hosokawa K, Nagata R, Higaki M, Igarashi R, Ebata T (1999) LTT Institute Co Ltd, Medicaments for nasal administration. U.S. Patent 5, 942,242.
Mori K, Dojo M, Yamashita H (2013). Pd and Pd–Ag nanoparticles within a macroreticular basic resin: an efficient catalyst for hydrogen production from formic acid decomposition. ACS Catal 3(6):1114-1119.
Payne WW (1956). Ion exchange resins in clinical medicine. J Pharm Pharmacol 8(1):397-402.
Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S (2004) Drug release properties of polyethylene-glycol-treated ciprofloxacin-Indion 234 complexes. AAPS Pharm Sci Tech 5(4):101-106.
Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S (2004) Molecular properties of ciprofloxacin-Indion 234 complexes. AAPS Pharm Sci Tech 5(4):84-91.
Plaizier-Vercammen JA (1992). Investigation of the bioavailability of codeine from a cation ion-exchange sulfonic acid: 1. Effect of parameters. Int J Pharm 85(1-3):45-50.
Praharaj S, Nath S, Ghosh SK, Kundu S, Pal T (2004). Immobilization and recovery of Au nanoparticles from anion exchange resin: resin-bound nanoparticle matrix as a catalyst for the reduction of 4-nitrophenol. Langmuir 20(23):9889-9892.
Raghunathan Y, Amsel L, Hinsvark O, Bryant W (1981). Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs. J Pharm Sci 70(4):379-384.
Roy GLENN (1997). General ingredient or process approaches to bitterness inhibition and reduction in oral pharmaceuticals. Modifying Bitterness: Mechanisms, Ingredients and Applications. Lancaster, PA: Technomic Publishing 285-320.
Saari P, Heikkila H, Hurme M (2010). Adsorption equilibria of arabinose, fructose, galactose, glucose, mannose, rhamnose, sucrose, and xylose on ion-exchange resins. J Chem Eng Data 55(9):3462-3467.
Sharma YC, Singh B, Korstad J (2011). Advancements in solid acid catalysts for ecofriendly and economically viable synthesis of biodiesel. Biofuel Bioprod Biorefin 5(1):69-92.
Shibasaki-Kitakawa N, Tsuji T, Chida K, Kubo M, Yonemoto T (2010). Simple continuous production process of biodiesel fuel from oil with high content of free fatty acid using ion-exchange resin catalysts. Energy & Fuels 24(6):3634-3638.
Siegel S (1962). Stabilization of Cold Tablets. J Pharm Sci 51:1069.
Simon G (1991). Ion Exchange Training Manual, New York: Van Nostrand Reinhold.
Sohi H, Sultana Y, Khar RK (2004). Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 30(5):429-448.
Sole KC, Mooiman MB, Hardwick E (2018). Ion exchange in hydrometallurgical processing: an overview and selected applications. Sep Purif Rev 47(2):159-178.
Srikanth MV, Sunil SA, Rao NS, Uhumwangho MU, Murthy KR (2010). Ion-exchange resins as controlled drug delivery carriers. Int J Sci Res 2(3):597-611.
Sriwongjanya M, Bodmeier R (1998). Effect of ion exchange resins on the drug release from matrix tablets. Eur J Pharm Biopharm 46(3):321-327.
Ulviya S, Amrita BN (2000). Oral controlled release bromhexine-ion exchange resinate suspension formulation. Indian Drugs-Bombay 37(4):185-189.
Van Abbe NJ, Rees JT (1998). An approach for development of oral sustained release suspension. J Am Pharm Assoc 47:487.
Van Rheenen PR (2004). Rohm and Haas Company, Coating Composition Containing Ion Exchange Resins. U.S. Patent 6, 815,466.
Vincent C, Warfield RB (1963). Bristol-Myers Co, Tablet Disintegrants. U.S. Patent 3, 091,574.
Xing Y, Chen X, Wang D (2007). Electrically regenerated ion exchange for removal and recovery of Cr (VI) from wastewater. Environ Sci Technol 41(4):1439-1443.
Yu L, Li S, Yuan Y, Dai Y, Liu H (2006). The delivery of ketoprofen from a system containing ion-exchange fibers. Int J Pharm 319(1-2):107-113.